The study demonstrates that EVs produced by RBCs from patients with T2D induce endothelial dysfunction through a mechanism involving increased uptake of EVs in endothelial cells, delivery of arginase-1, and induction of vascular oxidative stress. Here, ARG1 is linked to endothelial dysfunction.